Cleared Traditional

K873784 - NOVA STREP A

K873784 is an FDA 510(k) clearance for NOVA STREP A, manufactured by Synbiotics Corp.. The device is a Class 1 Microbiology device with product code GTZ cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K873784 · Synbiotics Corp. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1987
Decision
56d
Days
Class 1
Risk

K873784 is an FDA 510(k) clearance for the NOVA STREP A. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Synbiotics Corp. (San Diego, US). The FDA issued a Cleared decision on November 12, 1987 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Synbiotics Corp. devices

FDA 510(k) Submission Details - K873784

510(k) Number K873784 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 1987
Decision Date November 12, 1987
Days to Decision 56 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 102d · This submission: 56d
Pathway characteristics
Predicate-based equivalence.

GTZ Device Classification - Class 1, General Controls

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 90
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K873784.
V-TREND STREP A TEST
K880483 · Texas Immunology, Inc. · Apr 1988
TARGET STREP A
K880460 · V-Tech, Inc. · Mar 1988
BINAX EQUATE STREP B
K872904 · Binax, Inc. · Nov 1987
SURE-STREP A TEST KIT CATALOG NO. MB-1083
K872346 · Medix Biotech, Inc. · Sep 1987
QTEST STREP
K872961 · Quidel Corp. · Sep 1987
BACTIGEN GROUP B STREPTOCOCCUS-CS TEST
K872114 · Armkel, LLC · Aug 1987